What DBG Health does

DBG Health is a privately held Australian health and wellbeing corporation headquartered in Melbourne that operates as a multi-subsidiary platform spanning pharmaceutical distribution, consumer health and beauty products, professional health services, independent pharmacy networks, and genetic testing. Its five operating units are Arrotex Pharmaceuticals (Australia's largest pharmaceutical provider, distributing branded, generic, biologic, biosimilar, and hospital medicines and fulfilling 1 in every 2 PBS scripts), VidaCorp Consumer Brands (house of market-leading brands including MCoBeauty, Chemists' Own, Nude by Nature, and APOHEALTH), AXE Health Services (engagement programs, nursing, telehealth, contract sales via Farmaforce, and continuing medical education through 5,861 participating pharmacies), Independent Pharmacies Australia (the largest network of independent community pharmacies with 1,000+ members), and myDNA Inc. (precision health and genetic genealogy through pharmacogenomic testing, nutrigenomics, hereditary screening, and ancestry via FamilyTreeDNA and Gene by Gene).

The platform generates revenue through a mix of distribution margins on prescription medicines, retail and private-label sales of OTC and beauty products, professional service fees, and genetic testing services. Underlying technology includes clinical-grade pharmacogenomic reporting (myDNA), CLIA/CAP-accredited next-generation sequencing at scale (Gene by Gene), pharmacy-based patient engagement IT (PharmaPrograms), and over-the-counter and prescription product portfolios totaling more than 1,373 prescription SKUs and 150+ OTC SKUs across 12 health categories. DBG serves an estimated 15 million patients and consumers, with 1,400+ employees globally and offices in Australia, New Zealand, the United States, the United Kingdom, the Netherlands, and Singapore.

Go-to-market is executed through channel partnerships with 24 multinational pharmaceutical companies for branded medicines, direct distribution to pharmacies and hospitals across Australia and New Zealand, retail distribution through major Australian and US retailers (Woolworths, BIG W, Chemist Warehouse, Target, Kroger), banner group networks for independent pharmacies, and direct-to-consumer genetic testing.

Name

DBG Health

Legal name

DBG Health

Website

https://dbghealth.com.au

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

DBG Health is an Australian health and wellbeing corporation operating five subsidiaries — Arrotex Pharmaceuticals, VidaCorp Consumer Brands, AXE Health Services, Independent Pharmacies Australia, and myDNA Inc. — to distribute prescription medicines, consumer health and beauty products, pharmacy support services, and genetic testing across Australia, New Zealand, the US, UK, Europe, and Singapore.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution and Consumer Health

NAICS

Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292), Medical and Diagnostic Laboratories (6215)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Services-Medical Laboratories (8071)

akta.pro primary industry

340B Program Administration & Contract Pharmacy Services (HLAFALAL)

akta.pro secondary industries

Pharmacy-Integrated Virtual Care & ePrescribing (Employer Benefit) (HLALADAH), De-identification, Tokenization & Privacy-Preserving Data Platforms (HLACAIAK)

Keywords

• Pharmaceutical distribution services
• Consumer health products
• Beauty brand portfolio
• Genetic testing services
• Pharmacy network support

Headquarters

HQ city

Melbourne

HQ country

Australia

HQ region

Oceania

Offices9 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Marketing or Sales, Operations, Technology or R&D, Infrastructure

Revenue model

1. Prescription Medicines Distribution: Arrotex distributes branded, generic, and innovative medicines across Australia and New Zealand, fulfilling 1 in every 2 PBS scripts. Offers over 350 prescription medicines across 1,298 prescription SKUs. Revenue derived from pharmaceutical supply to pharmacies and hospitals, representing Australia's largest pharmaceutical provider.
2. Consumer Health and Beauty Products: VidaCorp sells OTC medicines (Chemists' Own, APOHEALTH), beauty products (MCoBeauty, Nude by Nature), and wellness products through major retailers and pharmacies. Products include 150+ OTC products across 12 health categories and luxury-for-less beauty products.
3. Health Services and Professional Programs: AXE Health Services generates revenue through professional service payments ($67M mentioned), nursing and telehealth services, contract sales teams, medical education programs, and pharmacy engagement programs. Services delivered through 5,861 participating pharmacies with 1.3M+ participating patients.
4. Genetic Testing Services: myDNA provides clinical genetic testing including pharmacogenetics, nutrigenomics, hereditary screening, and polygenic risk scores. Also offers ancestry/genealogy services through FamilyTreeDNA. Testing completed for 100K+ myDNA users with 5.4M+ samples processed by Gene by Gene over 5 years.

Go-to-market motion4 records

Distribution channels6 records

Marketing channels5 records

Core offering

DBG Health is an Australian health and wellbeing corporation operating five integrated business units: Arrotex Pharmaceuticals distributes prescription medicines fulfilling 1 in 2 PBS scripts across Australia; VidaCorp Consumer Brands markets OTC medicines, beauty, and wellness products through major retailers; AXE Health Services delivers pharmacy engagement, nursing, telehealth, contract sales, and medical education programs; Independent Pharmacies Australia (IPA) unifies over 1,000 independent community pharmacies across banner groups; and myDNA Inc. provides pharmacogenomic, hereditary, and ancestry genetic testing through Gene by Gene and FamilyTreeDNA.

Product overview

DBG Health is an Australian health and wellbeing corporation operating a multi-subsidiary platform structure with five distinct business units: Arrotex Pharmaceuticals (Australia's largest pharmaceutical provider offering prescription, generic, branded, biologic, biosimilar, and hospital medicines), VidaCorp Consumer Brands (health, wellness, personal care, and beauty products including market leaders MCoBeauty, Chemists' Own, Nude by Nature, and APOHEALTH), AXE Health Services (strategic solutions for pharmacies including pharmacy engagement, nursing, telehealth, consulting, contract sales, medical education, and consumer diagnostics), Independent Pharmacies Australia (network of independent community pharmacies operating under multiple banners including IPA, Advantage Pharmacy, and Alliance Pharmacy), and myDNA Inc. (precision health and genetic genealogy services including pharmacogenetics, nutrigenomics, hereditary screening, and ancestry testing through Gene by Gene and FamilyTreeDNA). The platform serves approximately 15 million patients and consumers through 1,400+ employees and partnerships with 141 global suppliers.

Differentiator

Problem solved

Functional benefit

Brands

• Arrotex Pharmaceuticals: Australia's largest and most diversified pharmaceutical provider offering the most extensive range of prescription products across the spectrum of therapeutic areas
• VidaCorp Consumer Brands
• AXE Health Services
• Independent Pharmacies Australia (IPA)
• myDNA Inc.
• MCoBeauty
• Chemists' Own
• Nude by Nature
• APOHEALTH
• Ferro-grad C
• Natalis
• FamilyTreeDNA
• Gene by Gene
• IPA (Independent Pharmacies Australia) Branded Pharmacy
• Advantage Pharmacy
• Alliance Pharmacy
• Pharmacy Catalyst
• Chemist Discount Centre
• PharmaPrograms
• Wellness
• Sinapse Health
• Farmaforce
• Praxhub
• Precision Health
• Juno
• OraDerm
• ArroVet

Products and services

• Arrotex Pharmaceuticals

Quantifiable outcome

• 50% of all PBS scripts fulfilled, saving taxpayers hundreds of millions of dollars annually
• +4 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and flagship.

• BupacoreStrategic or Co-development Partner · 1 January 2025myDNA and Bupa partnership to launch genetic testing program, providing Bupa members access to myDNA's pharmacogenomic testing services for personalized medicine and health insights.
• Melbourne Business SchoolflagshipStrategic or Co-development Partner · 1 January 2025DBG established the Bastas Academy of Health Leadership in partnership with Melbourne Business School, aiming to address critical leadership and workforce challenges within the global health sector through executive education programs.
• University of Melbourne Faculty of Medicine, Dentistry and Health SciencesflagshipStrategic or Co-development Partner · 1 January 2025Joint founding partner with Melbourne Business School in the Bastas Academy of Health Leadership, providing academic credibility and health sciences expertise for leadership development programs.
• Dong-A STcoreTechnology or Integration · 1 January 2025Arrotex signed exclusive licensing agreement with Korea-based Dong-A ST to provide innovative medicines for Australian patients through Arrotex's platform and infrastructure.
• George MedicinescoreTechnology or Integration · 1 January 2025Arrotex partnered with George Medicines to deliver innovation in hypertension treatment, providing Australian patients access to new therapeutic approaches.
• AntengenecoreTechnology or Integration · 1 January 2025Arrotex partnered with Antengene for therapy targeting multiple myeloma, expanding access to innovative cancer treatments for Australian patients.
• Juniper BiologicscoreTechnology or Integration · 1 January 2025Arrotex entered exclusive partnership with Juniper Biologics for strategic growth in the biologics space, enhancing Arrotex's innovative medicines portfolio.
• CelltrioncoreTechnology or Integration · 1 January 2025Arrotex and Celltrion launched two first-to-market biosimilars, providing more affordable biologic treatment options for Australian patients.

Scale indicators21 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Sigma Healthcare: Sigma Healthcare is Australia's other major pharmaceutical wholesaler and distributor, competing head-to-head with Arrotex for pharmacy supply contracts and PBS distribution share. The two companies are the closest comparables on the Arrotex side of DBG's portfolio.
• EBOS Group: EBOS is the leading Australasian pharmaceutical, animal care, and consumer healthcare distributor with operations across NZ and Australia. Comparable to DBG's Arrotex pharmaceutical distribution and ArroVet animal health businesses across similar geographies.
• 23andMe: 23andMe is a leading direct-to-consumer genetic testing company offering ancestry and health risk reports, directly comparable to myDNA's precision health and FamilyTreeDNA's genetic genealogy services. Both compete for consumer genetic data and pharmacogenomic insights.
• Ancestry: Ancestry operates one of the world's largest consumer genetic genealogy databases, directly comparable to FamilyTreeDNA. Both monetize large genetic databases through subscription ancestry and increasingly through health insights partnerships.

Broad incumbents

• Wesfarmers Health (Australian Pharmaceutical Industries): Wesfarmers Health owns API (pharmaceutical distribution) and Priceline Pharmacy, making it a broad incumbent competitor across pharma distribution, pharmacy retail, and consumer health. Comparable to DBG's combined Arrotex and IPA offerings.
• Sonic Healthcare: Sonic Healthcare is one of Australia's largest diagnostics and pathology providers with global operations, making it a relevant comparable to myDNA/Gene by Gene's genetic testing and laboratory services. Also overlaps with broader health platform strategies.
• L'Oréal Australia: L'Oréal is the global beauty incumbent with significant Australian operations through brands like Maybelline and Lancôme, directly competing with MCoBeauty and Nude by Nature in mass and masstige beauty channels including Chemist Warehouse and Target/Kroger.
• Estée Lauder Companies: Estée Lauder is a global prestige beauty conglomerate whose brand portfolio (MAC, Bobbi Brown, Clinique) competes with Nude by Nature and MCoBeauty in department stores, specialty beauty, and pharmacy channels across the same retailers DBG supplies.
• CSL Limited: CSL is Australia's largest biotech company and a global plasma/biologics leader, providing a relevant comparable for DBG's biologics and biosimilars expansion (Celltrion, Antengene partnerships) and as a benchmark Australian healthcare platform of similar scale.

Regional players

• Chemist Warehouse: Chemist Warehouse is Australia's largest discount pharmacy retailer and a key distribution and shelf-space partner for DBG's Chemists' Own, APOHEALTH, and MCoBeauty brands. Competes with IPA's independent banner groups for retail share while also being a customer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/dbg-health

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DBG Health